Cargando…
Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway
Background: Psoriasis is a chronic, immune-mediated inflammatory skin disease, and the inflammatory response plays an important role in its development and progression. Datura metel L. is a traditional Chinese medicine that exhibited a significant therapeutic effect on psoriasis in our previous stud...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600670/ https://www.ncbi.nlm.nih.gov/pubmed/31181689 http://dx.doi.org/10.3390/molecules24112157 |
_version_ | 1783431161324765184 |
---|---|
author | Yang, Bing-You Cheng, Yan-Gang Liu, Yan Liu, Yuan Tan, Jin-Yan Guan, Wei Guo, Shuang Kuang, Hai-Xue |
author_facet | Yang, Bing-You Cheng, Yan-Gang Liu, Yan Liu, Yuan Tan, Jin-Yan Guan, Wei Guo, Shuang Kuang, Hai-Xue |
author_sort | Yang, Bing-You |
collection | PubMed |
description | Background: Psoriasis is a chronic, immune-mediated inflammatory skin disease, and the inflammatory response plays an important role in its development and progression. Datura metel L. is a traditional Chinese medicine that exhibited a significant therapeutic effect on psoriasis in our previous study due to its remarkable anti-inflammatory effect. Meanwhile, the mechanism underlying its effects on psoriasis is still unclear. Methods: An imiquimod-induced psoriasis-like dermatitis mouse model was constructed to evaluate the protective effect of the effective part of Datura metel L. (EPD), which was verified by evaluations of the Psoriasis Area and Severity Index (PASI) score. Hematoxylin and eosin (H&E) staining, immunohistochemical examination, enzyme-linked immunosorbent assay (ELISA), and Western blot were used to measure the inflammatory cytokines and the protein expression associated with the Toll-like receptor 7– myeloid differentiation primary response gene 88–nuclear Factor-κB–nucleotide-binding oligomerization domain (Nod)-like receptor family pyrin domain-containing 3 (TLR7/8–MyD88–NF-κB–NLRP3) inflammasome pathway. Results: EPD significantly decreased the PASI, reduced epidermal thickness, and decreased the proliferation and differentiation of epidermal cells in psoriasis-like dermatitis C57BL/6 mice induced by imiquimod (IMQ). Furthermore, EPD reduced the infiltration of CD3+ cells to psoriatic lesions, as well as ameliorated the elevations of intercellular adhesion molecule 1 (ICAM-1) and inhibited the production of imiquimod-induced inflammatory cytokines, including IL-1β, IL-2, IL-6, IL-10, IL-12, IL-17, IL-22, IL-23, tumor necrosis factor-α (TNF-α), monocyte chemotactic protein 1 (MCP-1), and interferon-γ (IFN-γ). Besides, EPD decreased the imiquimod-induced expression levels of TLR7, TLR8, TRAF6, MyD88, p-IKKα, p-IKBα, p-NF-κB, NLRP3, apoptosis-associated speck-like protein contained a caspase recruitment domain (ASC), cysteinyl aspartate specific proteinase 1 (caspase-1), and IL-1β. Conclusion: This study demonstrated that EPD exhibited a protective effect on an imiquimod-induced psoriasis mice model by inhibiting the inflammatory response, which might be ascribed to the inhibition of the TLR7/8–MyD88–NF-κb–NLRP3 inflammasome pathway. |
format | Online Article Text |
id | pubmed-6600670 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-66006702019-07-16 Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway Yang, Bing-You Cheng, Yan-Gang Liu, Yan Liu, Yuan Tan, Jin-Yan Guan, Wei Guo, Shuang Kuang, Hai-Xue Molecules Article Background: Psoriasis is a chronic, immune-mediated inflammatory skin disease, and the inflammatory response plays an important role in its development and progression. Datura metel L. is a traditional Chinese medicine that exhibited a significant therapeutic effect on psoriasis in our previous study due to its remarkable anti-inflammatory effect. Meanwhile, the mechanism underlying its effects on psoriasis is still unclear. Methods: An imiquimod-induced psoriasis-like dermatitis mouse model was constructed to evaluate the protective effect of the effective part of Datura metel L. (EPD), which was verified by evaluations of the Psoriasis Area and Severity Index (PASI) score. Hematoxylin and eosin (H&E) staining, immunohistochemical examination, enzyme-linked immunosorbent assay (ELISA), and Western blot were used to measure the inflammatory cytokines and the protein expression associated with the Toll-like receptor 7– myeloid differentiation primary response gene 88–nuclear Factor-κB–nucleotide-binding oligomerization domain (Nod)-like receptor family pyrin domain-containing 3 (TLR7/8–MyD88–NF-κB–NLRP3) inflammasome pathway. Results: EPD significantly decreased the PASI, reduced epidermal thickness, and decreased the proliferation and differentiation of epidermal cells in psoriasis-like dermatitis C57BL/6 mice induced by imiquimod (IMQ). Furthermore, EPD reduced the infiltration of CD3+ cells to psoriatic lesions, as well as ameliorated the elevations of intercellular adhesion molecule 1 (ICAM-1) and inhibited the production of imiquimod-induced inflammatory cytokines, including IL-1β, IL-2, IL-6, IL-10, IL-12, IL-17, IL-22, IL-23, tumor necrosis factor-α (TNF-α), monocyte chemotactic protein 1 (MCP-1), and interferon-γ (IFN-γ). Besides, EPD decreased the imiquimod-induced expression levels of TLR7, TLR8, TRAF6, MyD88, p-IKKα, p-IKBα, p-NF-κB, NLRP3, apoptosis-associated speck-like protein contained a caspase recruitment domain (ASC), cysteinyl aspartate specific proteinase 1 (caspase-1), and IL-1β. Conclusion: This study demonstrated that EPD exhibited a protective effect on an imiquimod-induced psoriasis mice model by inhibiting the inflammatory response, which might be ascribed to the inhibition of the TLR7/8–MyD88–NF-κb–NLRP3 inflammasome pathway. MDPI 2019-06-07 /pmc/articles/PMC6600670/ /pubmed/31181689 http://dx.doi.org/10.3390/molecules24112157 Text en © 2019 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Yang, Bing-You Cheng, Yan-Gang Liu, Yan Liu, Yuan Tan, Jin-Yan Guan, Wei Guo, Shuang Kuang, Hai-Xue Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway |
title | Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway |
title_full | Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway |
title_fullStr | Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway |
title_full_unstemmed | Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway |
title_short | Datura Metel L. Ameliorates Imiquimod-Induced Psoriasis-Like Dermatitis and Inhibits Inflammatory Cytokines Production through TLR7/8–MyD88–NF-κB–NLRP3 Inflammasome Pathway |
title_sort | datura metel l. ameliorates imiquimod-induced psoriasis-like dermatitis and inhibits inflammatory cytokines production through tlr7/8–myd88–nf-κb–nlrp3 inflammasome pathway |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6600670/ https://www.ncbi.nlm.nih.gov/pubmed/31181689 http://dx.doi.org/10.3390/molecules24112157 |
work_keys_str_mv | AT yangbingyou daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway AT chengyangang daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway AT liuyan daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway AT liuyuan daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway AT tanjinyan daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway AT guanwei daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway AT guoshuang daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway AT kuanghaixue daturametellamelioratesimiquimodinducedpsoriasislikedermatitisandinhibitsinflammatorycytokinesproductionthroughtlr78myd88nfkbnlrp3inflammasomepathway |